GLDC
Glycine dehydrogenase (decarboxylating), mitochondrial
Also known as: GCSP, GCSP_HUMAN, NKH
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P23378
- Gene
- GLDC
- Ensembl
- ENSG00000178445
- Chromosome
- 9
- Canonical length
- 1020 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Degradation of glycine is brought about by the glycine cleavage system, which is composed of four mitochondrial protein components: P protein (a pyridoxal phosphate-dependent glycine decarboxylase), H protein (a lipoic acid-containing protein), T protein (a tetrahydrofolate-requiring enzyme), and L protein (a lipoamide dehydrogenase). The protein encoded by this gene is the P protein, which binds to glycine and enables the methylamine group from glycine to be transferred to the T protein. Defects in this gene are a cause of nonketotic hyperglycinemia (NKH).[provided by RefSeq, Jan 2010]
Canonical amino-acid sequenceUniProt
1020 residues, UniProt reviewed canonical sequence.
>P23378|GLDC
1 MQSCARAWGL RLGRGVGGGR RLAGGSGPCW APRSRDSSSG GGDSAAAGAS RLLERLLPRH
61 DDFARRHIGP GDKDQREMLQ TLGLASIDEL IEKTVPANIR LKRPLKMEDP VCENEILATL
121 HAISSKNQIW RSYIGMGYYN CSVPQTILRN LLENSGWITQ YTPYQPEVSQ GRLESLLNYQ
181 TMVCDITGLD MANASLLDEG TAAAEALQLC YRHNKRRKFL VDPRCHPQTI AVVQTRAKYT
241 GVLTELKLPC EMDFSGKDVS GVLFQYPDTE GKVEDFTELV ERAHQSGSLA CCATDLLALC
301 ILRPPGEFGV DIALGSSQRF GVPLGYGGPH AAFFAVRESL VRMMPGRMVG VTRDATGKEV
361 YRLALQTREQ HIRRDKATSN ICTAQALLAN MAAMFAIYHG SHGLEHIARR VHNATLILSE
421 GLKRAGHQLQ HDLFFDTLKI QCGCSVKEVL GRAAQRQINF RLFEDGTLGI SLDETVNEKD
481 LDDLLWIFGC ESSAELVAES MGEECRGIPG SVFKRTSPFL THQVFNSYHS ETNIVRYMKK
541 LENKDISLVH SMIPLGSCTM KLNSSSELAP ITWKEFANIH PFVPLDQAQG YQQLFRELEK
601 DLCELTGYDQ VCFQPNSGAQ GEYAGLATIR AYLNQKGEGH RTVCLIPKSA HGTNPASAHM
661 AGMKIQPVEV DKYGNIDAVH LKAMVDKHKE NLAAIMITYP STNGVFEENI SDVCDLIHQH
721 GGQVYLDGAN MNAQVGICRP GDFGSDVSHL NLHKTFCIPH GGGGPGMGPI GVKKHLAPFL
781 PNHPVISLKR NEDACPVGTV SAAPWGSSSI LPISWAYIKM MGGKGLKQAT ETAILNANYM
841 AKRLETHYRI LFRGARGYVG HEFILDTRPF KKSANIEAVD VAKRLQDYGF HAPTMSWPVA
901 GTLMVEPTES EDKAELDRFC DAMISIRQEI ADIEEGRIDP RVNPLKMSPH SLTCVTSSHW
961 DRPYSREVAA FPLPFVKPEN KFWPTIARID DIYGDQHLVC TCPPMEVYES PFSEQKRASSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GLDC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.21
- Highest tissue expression
- 173 nTPM
Expression across tissuesHPA
Tissue
- liver: 173 nTPM
- kidney: 36 nTPM
- cerebral cortex: 15 nTPM
- placenta: 14 nTPM
- amygdala: 12 nTPM
- basal ganglia: 8.5 nTPM
Single-cell type
- renal connecting tubule cells: 253 nCPM
- retinal pigment epithelial cells: 230 nCPM
- cytotrophoblasts: 191 nCPM
- proximal tubule cells: 171 nCPM
- hepatocytes: 166 nCPM
- distal convoluted tubule cells: 143 nCPM
Immune cell
- memory B-cell: 0.8 nTPM
- basophil: 0.4 nTPM
- neutrophil: 0.4 nTPM
- total PBMC: 0.3 nTPM
- classical monocyte: 0.1 nTPM
- eosinophil: 0.1 nTPM
Brain region
- hypothalamus: 14 nTPM
- cerebral cortex: 13 nTPM
- basal ganglia: 13 nTPM
- white matter: 13 nTPM
- cerebellum: 11 nTPM
- amygdala: 10 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GLDC.
Disease | AllUniProt
Conditions GLDC is implicated in, by any mechanism.
- Non-ketotic hyperglycinemia (NKH) MIM:605899
Disease | GeneticClinVar
488 pathogenic / likely-pathogenic of 2,623 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.11
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.59
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to leukemia inhibitory factor
- glycine catabolic process
- glycine decarboxylation via glycine cleavage system
- response to lipoic acid
- response to methylamine
Molecular functions
- electron transfer activity
- glycine binding
- lyase activity
- protein homodimerization activity
- pyridoxal phosphate binding
- glycine dehydrogenase (decarboxylating) activity
- pyridoxal binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Pyridoxal phosphate-dependent transferase, major domain
- Pyridoxal phosphate-dependent transferase, small domain
- Pyridoxal phosphate-dependent transferase
- Aromatic amino acid beta-eliminating lyase/threonine aldolase
- Glycine dehydrogenase (decarboxylating)
- Glycine cleavage system P protein
- Glycine cleavage system P-protein, N-terminal domain
- Glycine dehydrogenase, C-terminal domain
- Beta-eliminating lyase
- Glycine cleavage system P-protein
- Glycine dehydrogenase, C-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GLDC in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GLDC as an antibody target. Whether an autoantibody or antibody against GLDC could matter depends on whether native GLDC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GLDC is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GLDC as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...